Non-Small Cell Lung Cancer Market to reach USD 10.53 Billion by 2026 | Tarceva, Avastin, Gemzar, Alimta, etc.

The Global Non-Small Cell Lung Cancer Market is forecast to reach USD 10.53 Billion by 2026, according to a new report by Reports and Data. Non-small cell lung cancer accounts for approximately 85% of all lung cancers. The rise in the number of people suffering from non-small cell lung cancer is one of the major factors driving the global non-small cell lung cancer drugs market growth. The risk factors such as air pollution, cigarette smoking, passive smoking, and occupational exposure are increasing the incidence of the disease globally.

Key participants include Tarceva, Avastin, Gemzar, Alimta, Taxotere, AstraZeneca, Roche, Merck KGa, Nlyte, and Panduit Corp. among others.

Have Queries? To request a sample or speak to an expert before you buy the report, click on the link below: https://www.reportsanddata.com/sample-enquiry-form/1475

One of the major drivers of the non-small cell lung cancer is the strong drug pipeline and recent drug approvals. The innovation of new drugs and their approvals for the treatment of the disease is anticipated to fuel the growth of the market.

One of the challenges of the non-small cell lung cancer market is the high cost of treatment. The disease can be treated by chemotherapy, surgery, targeted therapies, radiation therapy, and immunotherapy, which is quite expensive. Thus, the high cost of the treatment will hamper the growth of the market.

For the purpose of this report, Reports and Data have segmented the global Non-Small Cell Lung Cancer Market on the basis of Histology, Treatment, Drug Class, and Region:

Histology Outlook (Revenue, USD Billion; 2016-2026)
o Squamous Cell Carcinoma
o Large Cell Carcinoma
o Adenocarcinoma

Treatment Outlook (Revenue, USD Billion; 2016-2026)
o Surgery
o Radiation
o Chemotherapy
o Targeted Therapy Drugs

Drug Class Outlook (Revenue, USD Billion; 2016-2026)
o Angiogenesis Inhibitor
o Epidermal Growth Factor Receptor Blocker
o Kinase Inhibitor
o Microtubule Stabilizer
o Folate Antimetabolites
o PD-1/ PD-L1 Inhibitor

Regional Outlook (Revenue, USD Billion; 2016-2026)
o North America (United States, Canada and Mexico)
o Europe (Germany, France, UK, Russia and Italy)
o Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
o South America (Brazil, Argentina, Colombia)

Do you have questions about the Report or want to inquire about a Discount? Ask our Expert @ https://www.reportsanddata.com/discount-enquiry-form/1475

Further key findings from the report suggest

Smoking causes ~90% of lung cancer cases. Constant exposure to the high level of air pollution and drinking water with a high level of arsenic increases the odds of lung cancer.

The most common type of non-small cell lung cancer are adenocarcinomas, squamous cell carcinoma, and large cell carcinomas.

Squamous cell carcinoma is the second most common form of lung cancer. This type of lung cancer is found in the middle of the lungs. It is forecasted to hold a market share of 37% in the year 2026.

Adenocarcinoma held a market share of 48% in the year 2018. The disease tends to develop in smaller airways such as bronchioles, breasts, prostate, pancreas, and colon.

Adenocarcinoma accounts for approximately more than 40% of lung cancer and is found mostly in women and grows more slowly than any other cancers.

Surgery is expected to grow at a CAGR of 6.8% during the forecast period. It is an option to be performed at an early stage and is the best chance to cure the disease.

Types of lung cancer surgeries include pneumonectomy, lobectomy, segmentectomy or wedge resection, and sleeve resection.

Chemotherapy is a treatment with anti-cancer drugs that are injected into a vein or taken by mouth. The treatment is useful for treating cancer anywhere in the body...Continued

Go through our meticulously drafted TOC, Tables, Statistics, Charts, and Company profiles @ https://www.reportsanddata.com/report-detail/non-small-cell-lung-cancer-market

In conclusion, the Non-Small Cell Lung Cancer Market report is a reliable source for accessing the Market data that will exponentially accelerate your business. The report provides the principal locale, economic scenarios with the item value, benefit, supply, limit, generation, request, Market development rate, and figure and so on. Besides, the report presents a new task SWOT analysis, speculation attainability investigation, and venture return investigation.

Contact Us:
Address: 40 Wall St. 28th floor New York City, NY 10005 United States
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About us:
Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and development analysis, and demand estimation among others, we can help you invest your funds in the most beneficial areas for research and development. You can rely on us to provide every significant detail you might need in your efforts to make your business flourish.

This release was published on openPR.